pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,159 catalysts · 5,159 phase readout · 2,327 8k filing · 316 pdufa · 275 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 32 catalysts2026-07-30: 13 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: device pma×clear all
type
  • phase readout5,159
  • 8k filing2,327
  • pdufa316
  • earnings275
  • phase 2 completion108
  • phase 1 completion50
phase 1 2 completion
28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›TERMINATEDphase readoutNCT06162351: A Study to Evaluate the Efficacy and Toxicities of PLX038, in Patients With Locally Advanced or Metastatic Triple-negative Breast Cancer

    Sponsor: Institut Curie. Phase: PHASE2. Conditions: Breast, Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02710331: Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III

    Sponsor: Yale University. Phase: PHASE1. Conditions: Cannabis, Alcohol Effect, Driving Under the Influence of Alcohol and Other Drugs

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06937931: A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults

    Sponsor: Ipsen. Phase: PHASE2. Conditions: Cervical Dystonia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07708402: Healing Stigma Through Stories

    Sponsor: National Yang Ming Chiao Tung University. Phase: NA. Conditions: Schizophrenia / Schizoaffective Disorder

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT06145802: Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Solid Tumors (Gynecological Tumors)

    Sponsor: Grit Biotechnology. Phase: NA. Conditions: Solid Tumor, Gynecological Tumors

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05609253: Itraconazole to Prevent Recurrent Barrett's Esophagus

    Sponsor: University of Kansas Medical Center. Phase: EARLY_PHASE1. Conditions: Barrett Oesophagitis With Dysplasia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07604753: Validation of the CIDI 5.0 Against the SCID-5 for Lifetime Mental Disorders

    Sponsor: The University of Hong Kong. Phase: . Conditions: Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), Posttraumatic Stress Disorder (PTSD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07282353: A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA

    Sponsor: Cascade Pharmaceuticals, Inc. Phase: PHASE3. Conditions: Primary Biliary Cholangitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03949153: Cryotherapy With in Situ Immunotherapy in Melanoma Metastasis

    Sponsor: University Hospital, Strasbourg, France. Phase: PHASE1. Conditions: Melanoma (Skin)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05338437: NMES in HF Patients to Improve Functional Recovery Following Hospitalization

    Sponsor: University of Vermont Medical Center. Phase: NA. Conditions: Heart Failure With Preserved Ejection Fraction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06792045: Prediction of Tongue Base Obstruction During Sleep

    Sponsor: Université Catholique de Louvain. Phase: . Conditions: Obstructive Sleep Disordered Breathing

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05171972: Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab Treatment

    Sponsor: University of Southern California. Phase: . Conditions: Relapsing Remitting Multiple Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06794372: [68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas

    Sponsor: John O. Prior. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma HNSCC

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07382895: The Relationship Between the ASA Score Determined by Operating Room Nurses and Intubation Duration

    Sponsor: Zonguldak Bulent Ecevit University. Phase: . Conditions: The Individual Must be 18 Years of Age or Older, The Individual Must be Willing to Participate in the Study

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05612295: Mindfulness-Based Peak Performance, Endurance Performance Under Pressure, Performance-relevant Mental Attributes

    Sponsor: National Taiwan Normal University. Phase: NA. Conditions: Mindfulness, Sport Performance, Neurocognitive Function, Stress

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05903339: Clinical Trial to Evaluate the Safety and Immunogenicity of Ferritin Nanoparticles Expressing Native-like HIV-1 Envelope Trimers Followed by Boost With mRNA Lipid Nanoparticles Encoding a Native-like HIV-1 Envelope Trimer in Adults Without HIV

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: Hiv

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06852339: Evaluating the EAPOC-COPD System

    Sponsor: Women's College Hospital. Phase: NA. Conditions: COPD

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07383077: Molecular Determinants of Spinal Cord Injury Rehabilitation

    Sponsor: Prof. Sandra Vieira. Phase: . Conditions: Spinal Cord Injury

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07637396: Ankle-Brachial Index Changes Post Exercise and Its Effects on Patient-Centered Outcomes and Gait

    Sponsor: Louisiana State University Health Sciences Center Shreveport. Phase: . Conditions: Peripheral Arterial Disease(PAD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05110846: A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus

    Sponsor: Carmot Therapeutics, Inc.. Phase: PHASE2. Conditions: Obesity, Overweight, Type 2 Diabetes Mellitus

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06404762: Tuberosity Versus Palatal Connective Tissue Graft on the Treatment of Single Maxillary Recession-type Defects

    Sponsor: Gazi University. Phase: NA. Conditions: Gingival Recession, Localized

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05448846: Exercise Program for Colorectal Older Patients

    Sponsor: Hospital General Universitario Gregorio Marañon. Phase: NA. Conditions: Colorectal Neoplasms, Aged

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06535646: Digital Health Technology for People With Mitochondrial Disease

    Sponsor: Neuroscience Research Australia. Phase: NA. Conditions: Mitochondrial Diseases

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07186946: Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, PK, PD, and Comparative Bioavailability of THRV-1268 in Obese Adult Participants

    Sponsor: Thryv Therapeutics, Inc.. Phase: PHASE1. Conditions: Heart Failure

    full page →ctgov ↗
    ›AVAILABLEphase readoutNCT07647627: Availability of Dibotatug (DR-01) Outside Clinical Trials Via Expanded Access for Eligible Participants

    Sponsor: Dren Bio. Phase: . Conditions:

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07621770: Nutritional Status in Adults With Diabetic Foot Ulcers

    Sponsor: Hvidovre University Hospital. Phase: . Conditions: Diabetic Foot Ulcers (DFU), Nutrition Assessment, Malnutrition (Calorie), Ulcer Foot, Dietary Intake Assessment, Bio-Impedance Measurements, Wound Healing

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06196073: Visceral Osteopathy in Functional Constipation

    Sponsor: Pamukkale University. Phase: NA. Conditions: Functional Constipation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06381973: Ventilation Distribution in COPD Patients During Breathing Exercises

    Sponsor: William Poncin, PT, PhD. Phase: NA. Conditions: Chronic Obstructive Pulmonary Disease, Healthy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07337369: Cultural Adaptation of CBTi for the Arab World

    Sponsor: Laval University. Phase: NA. Conditions: Insomnia Disorder, Insomnia, Cultural Adaptation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07326969: MOVEMENT ANALYSIS IN PATIENTS UNDERGOING VERTEBRECTOMIES FOR SPINE ONCOLOGY: A PILOT STUDY

    Sponsor: Istituto Ortopedico Rizzoli. Phase: . Conditions: Spine Tumor, Vertebral Metastasis, Vertebral Column Mass

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07356583: Neonatal Enterovirus Infections in Italy: Virological Characterization, Genomic and Clinical-epidemiological Insights on Echovirus 11

    Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia. Phase: . Conditions: Enterovirus, Clinical Syndrome, Respiratory Complications, Gastrointestinal, Sepsis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05648383: Promote Health With Digital Tools Among Adults With Type 2 Diabetes/Prediabetes and/or Hypertension

    Sponsor: Harokopio University. Phase: NA. Conditions: Type 2 Diabetes, PreDiabetes, Hypertension, Obesity & Overweight

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05975905: A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).

    Sponsor: Keros Therapeutics, Inc.. Phase: PHASE2. Conditions: Pulmonary Arterial Hypertension

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07686705: Intravenous Versus Intra-articular Tranexamic Acid for Visual Clarity During Arthroscopic Rotator Cuff Repair

    Sponsor: Konkuk University Medical Center. Phase: NA. Conditions: Rotator Cuff Tears

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07305805: A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes

    Sponsor: Novo Nordisk A/S. Phase: PHASE1. Conditions: Diabetes Mellitus, Type 1

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07597005: Red Propolis Supplementation as a Strategy in Chronic Kidney Disease

    Sponsor: Universidade Federal Fluminense. Phase: NA. Conditions: Kidney Disease, Oxidative Stress, Chronic Kidney Disease, Inflammation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05260905: Predictors of Affective Responses to Sprint Interval Exercise

    Sponsor: University of Stirling. Phase: . Conditions: General Health

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06305754: Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Non-small Cell Lung Cancer (NSCLC)

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04809766: Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

    Sponsor: Fred Hutchinson Cancer Center. Phase: PHASE1. Conditions: Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07481266: Single-Window Versus Two-Window Posterolateral Approach for Malleolar Fractures

    Sponsor: muhammed kılıç. Phase: NA. Conditions: Ankle Fractures, Posterior Malleolus Fractures, Lateral Malleolus Fracture

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04612166: Medication Empowerment and Deprescription for Safety (MEDS) Study

    Sponsor: University of Iowa. Phase: NA. Conditions: Aging, Fall Injury

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03446456: Vasopressin and Pain Perception in the Brain

    Sponsor: University of Maryland, Baltimore. Phase: PHASE1. Conditions: Acute Pain

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03741751: Repetitive TMS & Cognitive Training in Adults With Schizophrenia

    Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Schizophrenia Spectrum and Other Psychotic Disorders, Cognitive Impairment

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07617051: PPIVMs for Cervicogenic Headache

    Sponsor: Jordan University of Science and Technology. Phase: NA. Conditions: Cervicogenic Headache

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07588529: Is Nipple Stimulation Effective for Inducing Labor and Acceptable to Patients, Nurses, and Providers?

    Sponsor: University of Kansas Medical Center. Phase: NA. Conditions: Pregnancy, Induction of Labor

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07367945: Incentive Spirometry Versus Inspiratory Muscle Training After Coronary Artery Bypass Grafting

    Sponsor: Cairo University. Phase: NA. Conditions: Coronary Artery Bypass Graft (CABG)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05331872: Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis

    Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology. Phase: PHASE1. Conditions: Liver Cirrhosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04547595: Hypnosis Intervention for the Management of Pain Perception During Joint Lavage

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE3. Conditions: Knee Osteoarthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05863195: Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

    Sponsor: ECOG-ACRIN Cancer Research Group. Phase: PHASE3. Conditions: Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver, Stage IV Colorectal Cancer AJCC v8, Unresectable Colorectal Carcinoma

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT04899895: Rheumatology Biorepository

    Sponsor: CorEvitas. Phase: . Conditions: Rheumatoid Arthritis

    full page →ctgov ↗
    ← prev
    page 101 of 104
    next →